Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 2 de 2
Filter
Add more filters











Database
Language
Publication year range
1.
BMC Res Notes ; 13(1): 258, 2020 May 26.
Article in English | MEDLINE | ID: mdl-32456668

ABSTRACT

OBJECTIVE: Nosocomial and community acquired multidrug resistant Klebsiella infections are wide spread resulting in high morbidity and mortality due to limited number of antibiotics treatment options. This study investigated efflux pump activity, biofilm forming potential and antibiotic susceptibility profile of Klebsiella spp. isolated from clinical samples in a tertiary hospital in Lagos Nigeria. Eighteen clinical Klebsiella spp. isolated from urine, blood and sputum were subjected to antibiotic susceptibility testing using the disc diffusion method. Efflux pump activity was evaluated by the ethidium bromide cartwheel method and biofilm forming ability was determined by the tissue culture plate technique. RESULTS: All 18 (100%) Klebsiella isolates were resistant to cefuroxime, cefixime, amoxicillin - clavulanate, ampicillin + cloxacillin, cefotaxime, and imipenem. Seventeen (94.4%) were resistant to ofloxacin while sixteen (88.9%) were resistance to nalidixic acid, Gentamicin and levofloxacin. All Klebsiella isolates possessed active efflux pump with the ability to form biofilm. However, their biofilm forming capabilities varied as 4 (22.2%) were strong, 3 (16.7%) were moderate and 11 (61.1%) were weak biofilm formers. Findings in this study reveal multiple factors at play in mediating the high level of antibiotic resistance observed in Klebsiella isolates. Hence a multifaceted approach is advocated in managing the infections caused by the pathogen.


Subject(s)
Anti-Bacterial Agents/pharmacology , Biofilms/drug effects , Drug Resistance, Multiple, Bacterial , Klebsiella/drug effects , Amoxicillin/pharmacology , Ampicillin/pharmacology , Cefuroxime/pharmacology , Cells, Cultured , Community-Acquired Infections , Drug Combinations , Hospitals, Teaching , Hospitals, University , Humans , Imipenem/pharmacology , Klebsiella/isolation & purification , Klebsiella/metabolism , Klebsiella/pathogenicity , Klebsiella Infections/blood , Klebsiella Infections/drug therapy , Klebsiella Infections/urine , Microbial Sensitivity Tests , Nigeria , Ofloxacin/pharmacology , Tertiary Care Centers
2.
J Glob Antimicrob Resist ; 13: 143-145, 2018 06.
Article in English | MEDLINE | ID: mdl-29355664

ABSTRACT

OBJECTIVES: The aim of this study was to determine the occurrence of 16S rRNA mutations associated with low-level tetracycline resistance in Helicobacter pylori isolates from adult dyspeptic patients in South West Nigeria. METHODS: Susceptibility testing to tetracycline of 50 H. pylori isolates was performed by Etest. The 535-bp conserved region of the H. pylori tetracycline-binding site of 16S rRNA was amplified by PCR, followed by sequencing and multiple sequence alignment for all 50 clinical isolates. RESULTS: Of the 50 clinical isolates examined, DNA sequence analysis revealed nucleotide substitutions in 7 isolates at positions 926-928. Of the seven isolates, two demonstrated reduced susceptibility to tetracycline with Etest minimum inhibitory concentrations (MICs) of 0.75-1.0mg/L, whilst the other five isolates were resistant with MICs of 1.5-24mg/L (resistance breakpoint >1mg/L). The two isolates with reduced susceptibility had single nucleotide substitution of A926G, whilst the five resistant isolates demonstrated double base pair substitutions of G927T/A928C and A926G/A928C and a single nucleotide substitution of A926G. CONCLUSIONS: This study shows that low-level tetracycline resistance amongst H. pylori-positive dyspeptic patients is associated with reduced susceptibility and resistance to tetracycline. This is the result of 1-bp and 2-bp differences in positions 926 and 926-928, respectively, in the 16S rRNA of H. pylori.


Subject(s)
Dyspepsia/microbiology , Helicobacter pylori/drug effects , Tetracycline Resistance/genetics , Tetracycline/pharmacology , Anti-Bacterial Agents , Biopsy , DNA, Bacterial/genetics , Dyspepsia/epidemiology , Helicobacter Infections/drug therapy , Helicobacter Infections/epidemiology , Helicobacter Infections/microbiology , Helicobacter pylori/isolation & purification , Humans , Microbial Sensitivity Tests , Mutation , Nigeria/epidemiology , RNA, Ribosomal, 16S/genetics , Sequence Analysis, DNA , Stomach/microbiology , Stomach/pathology , Tetracycline/therapeutic use
SELECTION OF CITATIONS
SEARCH DETAIL